Titlebook: Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?; Van Anh Le Book 2022 The Editor(s) (if ap

genial

書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?影響因子(影響力)




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?影響因子(影響力)學科排名




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?網(wǎng)絡(luò)公開度




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?網(wǎng)絡(luò)公開度學科排名




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?被引頻次




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?被引頻次學科排名




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?年度引用




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?年度引用學科排名




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?讀者反饋




書目名稱Compulsory Patent Licensing and Access to Medicines: A Silver Bullet Approach to Public Health?讀者反饋學科排名

Notify

International Patent Law and the Pharmaceutical Industry,ry, and to highlight the benefits and disbenefits associated with patent innovation. As will be critically evaluated in this chapter, the international patent system, from the Paris Convention to the TRIPS Agreement, has been significantly bolstered. To the world’s pharmaceutical industry, TRIPS is

背景

Heterodoxy

靈敏

Medley

Access to Medicines and Multilateral Organisations,ich in one way or another all take part in the ongoing deliberations of access to medicine. This chapter aims at establishing and analysing the stance of the four aforementioned organisations and determines to what extent their roles influence the world’s access to medicine policies, particularly th

Medley

meritorious

IPS flexibilities.This timely monograph focuses on India and Brazil’s use of compulsory licensing, one of the most significant and controversial TRIPS flexibilities. This is a topical work at this critical time when the COVID-19 has stirred up the debate about compulsory licensing and access to medi

neolith

https://doi.org/10.1007/978-3-531-91596-8wned by Bayer. While this historic decision seemed to herald a new era of compulsory licensing in the region, the Controller, unexpectedly, turned down two subsequent applications made by private companies, in late 2013 and early 2016. By examine these three applications, this chapter is to yield new insights into the Indian situation.

逢迎白雪

The Indian Case Study of Compulsory Licensing,wned by Bayer. While this historic decision seemed to herald a new era of compulsory licensing in the region, the Controller, unexpectedly, turned down two subsequent applications made by private companies, in late 2013 and early 2016. By examine these three applications, this chapter is to yield new insights into the Indian situation.